Clinical Trial Update: Efficacy and Safety of Iguratimod in Patients With Hand Osteoarthritis (ESIGO) [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating Iguratimod for hand osteoarthritis assessing efficacy and safety; results not disclosed in provided snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hand Osteoarthritis
• Inflammatory Arthritis

Drugs mentioned

• Iguratimod (iguratimod)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Hand Osteoarthritis, Inflammatory Arthritis | Phase 2, Phase 3 | Status: UNKNOWN